By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
TLSI insiders were on both sides of the trade this year. Buys came to roughly $3.6 million (six buyers), sales to $140,000 (five sellers).
The largest purchase came from Stansky Michael P (Director), about $1 million. Notably, at least one C-suite executive was among the buyers.
No open-market insider buying or selling in the last full quarter. Insiders bought in 3 of the last 7 full quarters. This quarter so far: net selling. Big money check: 78 institutions held TLSI as of Q2 2026, and more funds bought than sold.
Are insiders buying or selling TLSI stock?
In the last 12 months TriSalus Life Sciences, Inc. insiders made open-market purchases worth about $3.6 million and sales worth about $140,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in TLSI?
The most recent open-market insider trade in TLSI was filed on 2026-10-07.
How many institutions own TLSI?
78 investment managers reported holding TLSI in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded TLSI?
No congressional trades in TLSI were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).